GPPL RIZATRIPTAN rizatriptan (as benzoate) 5 mg orally disintegrating tablets blisters

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)

Tilgængelig fra:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

rizatriptan benzoate

Lægemiddelform:

Tablet, orally disintegrating

Sammensætning:

Excipient Ingredients: hypromellose; mannitol; silicon dioxide; crospovidone; acesulfame potassium; colloidal anhydrous silica; sodium stearylfumarate; ethylcellulose; Flavour

Indgivelsesvej:

Sublingual

Enheder i pakken:

6, 2, 3

Recept type:

(S4) Prescription Only Medicine

Terapeutiske indikationer:

for acute treatment of migraine attacks with or without aura.

Produkt oversigt:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C6' on one side and 'C' on the other side, having a characteristic flavour; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorisation status:

Licence status A

Autorisation dato:

2015-03-20